US Stock MarketDetailed Quotes
BIIB Biogen
- 208.900
- +6.440+3.18%
Close Apr 26 16:00 ET
- 208.500
- -0.400-0.19%
Post 19:51 ET
30.42BMarket Cap26.11P/E (TTM)
210.830High199.100Low1.89MVolume201.220Open202.460Pre Close394.24MTurnover1.31%Turnover Ratio26.21P/E (Static)145.60MShares319.76052wk High2.00P/B30.30BFloat Cap189.44052wk Low--Dividend TTM145.05MShs Float480.180Historical High--Div YieldTTM5.79%Amplitude2.625Historical Low208.143Avg Price1Lot Size
Biogen Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 21.50%553.2M | 11.77%1.55B | 107.14%12.5M | -10.38%592.4M | -33.88%487M | 181.40%455.3M | -61.97%1.38B | -120.88%-175M | -17.92%661M | -39.99%736.5M |
| Net income from continuing operations | 1.50%393.4M | -60.78%1.16B | -54.70%248.9M | -106.02%-68.3M | -43.96%593.3M | 77.39%387.6M | 71.43%2.96B | 2,780.49%549.5M | 256.89%1.13B | 3.24%1.06B |
| Operating gains losses | -60.68%31.3M | 115.87%277.1M | -98.67%1.4M | 149.37%302.5M | 92.58%-106.4M | -59.05%79.6M | -320.46%-1.75B | 7.10%105.6M | -243.89%-612.7M | -661.07%-1.43B |
| Depreciation and amortization | 31.34%147.5M | -4.55%494.8M | 16.94%140.1M | 3.56%125M | -12.91%117.4M | -21.52%112.3M | 6.29%518.4M | -11.06%119.8M | -9.38%120.7M | 15.02%134.8M |
| Deferred tax | 161.86%39.9M | -81.38%-305.8M | 349.65%71.9M | -124.05%-206.8M | -119.38%-106.4M | -6,550.00%-64.5M | 60.50%-168.6M | -108.91%-28.8M | 27.49%-92.3M | 92.02%-48.5M |
| Other non cash items | 98.77%97M | -9.31%304.1M | 219.10%143.4M | 28.08%63.4M | -45.20%48.5M | -84.64%48.8M | -0.53%335.3M | -172.01%-120.4M | -32.19%49.5M | 50.00%88.5M |
| Change In working capital | -24.23%-228.7M | 27.14%-648.7M | 34.37%-648.1M | 11,744.44%314.4M | -114.87%-130.9M | 76.41%-184.1M | -511.89%-890.3M | -1,395.93%-987.5M | 97.68%-2.7M | 289.56%880.4M |
| -Change in receivables | -26.48%84.4M | 125.49%56.7M | 218.38%130.1M | -309.72%-88.5M | -279.09%-99.7M | 277.71%114.8M | -168.22%-222.4M | -171.04%-109.9M | 31.43%-21.6M | -121.59%-26.3M |
| -Change in inventory | -378.49%-77.7M | 59.12%-130.9M | -630.39%-96M | 131.79%30.2M | 7.65%-93M | 119.57%27.9M | 30.75%-320.2M | 112.95%18.1M | 26.24%-95M | -23.86%-100.7M |
| -Change in payables and accrued expense | 39.97%-177.1M | -77.78%-201.6M | 33.55%-495.5M | 24,864.71%421M | -84.68%167.9M | 36.09%-295M | -18.87%-113.4M | -604.19%-745.7M | 96.90%-1.7M | 1,050.84%1.1B |
| -Change in other working capital | -83.33%-58.3M | -59.15%-372.9M | -24.47%-186.7M | -141.78%-48.3M | -20.29%-106.1M | 71.53%-31.8M | -371.49%-234.3M | -73.21%-150M | 17.12%115.6M | -197.67%-88.2M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 21.50%553.2M | 11.77%1.55B | 107.14%12.5M | -10.38%592.4M | -33.88%487M | 181.40%455.3M | -61.97%1.38B | -120.88%-175M | -17.92%661M | -39.99%736.5M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 93.07%-66M | -360.12%-4.1B | -362.30%-652.3M | -204.19%-1.74B | -208.65%-753.5M | -47.07%-953M | 379.69%1.58B | -25.20%-141.1M | 815.84%1.67B | 554.16%693.5M |
| Net PPE purchase and sale | 31.08%-45.9M | -180.92%-277M | 24.54%-65.2M | -114.17%-74.2M | -92.41%-71M | -15.03%-66.6M | 232.62%342.3M | -67.44%-86.4M | 1,346.43%523.5M | 48.68%-36.9M |
| Net intangibles purchase and sale | -1,400.00%-75M | -1,086.21%-34.4M | --0 | ---13.4M | -742.11%-16M | ---5M | 92.12%-2.9M | 94.08%-1M | --0 | ---1.9M |
| Net business purchase and sale | ---- | -719.81%-6.14B | ---590.5M | ---6.34B | ---- | ---- | 3,424.20%990.3M | --0 | --0 | ---- |
| Net investment purchase and sale | 106.31%55.6M | 960.54%2.36B | 117.56%13.4M | 307.45%4.68B | -458.88%-1.45B | -49.30%-880.7M | 171.82%222.5M | -35.04%-76.3M | 774.63%1.15B | -224.84%-260.2M |
| Net other investing changes | 0.00%-700K | -146.31%-11.3M | -144.25%-10M | 0.00%-200K | -118.18%-400K | -250.00%-700K | 89.15%24.4M | 83.74%22.6M | 85.71%-200K | 414.29%2.2M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 93.07%-66M | -360.12%-4.1B | -362.30%-652.3M | -204.19%-1.74B | -208.65%-753.5M | -47.07%-953M | 379.69%1.58B | -25.20%-141.1M | 815.84%1.67B | 554.16%693.5M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -912.90%-439.6M | 108.54%149.3M | -8,631.08%-646.1M | 167.78%848.6M | 97.92%-9.8M | -163.03%-43.4M | 16.24%-1.75B | -175.51%-7.4M | -67.70%-1.25B | 16.47%-471.5M |
| Net issuance payments of debt | ---400M | 118.69%187.3M | ---650M | ---- | ---- | --0 | -489.53%-1B | --0 | ---- | ---- |
| Net common stock issuance | ---- | --0 | --0 | --0 | ---- | ---- | 58.33%-750M | --0 | 66.67%-250M | ---- |
| Proceeds from stock option exercised by employees | 21.96%-46.9M | -2,231.58%-44.3M | -5.13%3.7M | 15.79%6.6M | -40.86%5.5M | -188.94%-60.1M | -171.43%-1.9M | -48.68%3.9M | -3.39%5.7M | -27.91%9.3M |
| Net other financing activities | -56.29%7.3M | -7.35%6.3M | 101.77%200K | 187.04%4.7M | -179.69%-15.3M | 288.37%16.7M | 105.89%6.8M | -613.64%-11.3M | -125.00%-5.4M | 115.15%19.2M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -912.90%-439.6M | 108.54%149.3M | -8,631.08%-646.1M | 167.78%848.6M | 97.92%-9.8M | -163.03%-43.4M | 16.24%-1.75B | -175.51%-7.4M | -67.70%-1.25B | 16.47%-471.5M |
| Net cash flow | ||||||||||
| Beginning cash position | -69.29%1.05B | 51.20%3.42B | -37.75%2.29B | -1.09%2.62B | 65.68%2.9B | 51.20%3.42B | 69.88%2.26B | 138.40%3.68B | 51.93%2.65B | 43.68%1.75B |
| Current changes in cash | 108.80%47.6M | -298.13%-2.4B | -297.50%-1.29B | -127.86%-301.2M | -128.83%-276.3M | -7.64%-541.1M | 22.59%1.21B | -143.99%-323.5M | 718.59%1.08B | 87.90%958.5M |
| Effect of exchange rate changes | -215.50%-23.1M | 163.02%35.1M | -28.72%47.9M | 45.12%-28.7M | 93.30%-4.1M | 312.77%20M | 6.86%-55.7M | 525.32%67.2M | -105.91%-52.3M | -525.00%-61.2M |
| End cash Position | -62.93%1.07B | -69.29%1.05B | -69.29%1.05B | -37.75%2.29B | -1.09%2.62B | 65.68%2.9B | 51.20%3.42B | 51.20%3.42B | 138.40%3.68B | 51.93%2.65B |
| Free cash flow | 12.67%432.3M | 8.30%1.24B | 79.92%-52.7M | -16.13%504.8M | -42.67%400M | 269.30%383.7M | -65.89%1.14B | -134.09%-262.4M | -19.03%601.9M | -39.61%697.7M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
